| Literature DB >> 35300447 |
Neha Kumari1, Tushar Kalonia1, Akanksha Malik1, Arvind Kumar1, Shalinee Rao1.
Abstract
Background: Fine-needle aspiration cytology remains the preliminary test for diagnosing papillary thyroid carcinoma (PTC). Numerous features are established to arrive at the diagnosis. However, few cases pose a challenge to correctly diagnose PTC. Our study aims to elicit the combination of features to aid in the diagnosis of such cases. Materials andEntities:
Keywords: Cellular swirls; PTC; papillae; papillary thyroid carcinoma
Year: 2022 PMID: 35300447 PMCID: PMC8923321 DOI: 10.4103/ijem.ijem_389_21
Source DB: PubMed Journal: Indian J Endocrinol Metab ISSN: 2230-9500
Comparison of demographic characteristics between groups 1 and 2
| Demographic characteristics | Group 1 ( | Group 2 ( | Total |
| Test performed |
|---|---|---|---|---|---|
| Age (years) | |||||
| Mean±SD | 38±15.65 | 36.05±12.43 | 37±14.02 | 0.554 | |
| Median (IQR) | 34 (25-50) | 35 (28-42.75) | 35 (25.25-44) | ||
| Range | 20-75 | 7-67 | 7-75 | ||
| Gender | |||||
| Female | 24 (66.67%) | 36 (94.74%) | 60 (81.08%) | 0.003 | Fisher’s Exact test |
| Male | 12 (33.33%) | 2 (5.26%) | 14 (18.92%) |
Categorization of groups 1 and 2 based on Bethesda system of thyroid reporting
| Bethesda category | Group 1 ( | Group 2 ( | Total |
| Test performed |
|---|---|---|---|---|---|
| II | 6 (16.67%) | 31 (81.58%) | 37 (50%) | <0.0001 | Fisher’s Exact test |
| III | 4 (11.11%) | 3 (7.89%) | 7 (9.46%) | ||
| IV | 1 (2.78%) | 4 (10.53%) | 5 (6.76%) | ||
| V | 2 (5.56%) | 0 (0%) | 2 (2.70%) | ||
| VI | 23 (63.89%) | 0 (0%) | 23 (31.08%) | ||
| Total | 36 (100%) | 38 (100%) | 74 (100%) |
Figure 1Comparison between groups 1 and 2 based on Bethesda category
Comparison of cytologic features between groups 1 and 2
| Cytologic features | Group 1 ( | Group 2 ( | Total |
| Test performed |
|---|---|---|---|---|---|
| Papillae with cores | |||||
| Absent | 14 (38.89%) | 32 (84.21%) | 46 (62.16%) | <0.0001 | Chi-square test, 16.144 |
| Present | 22 (61.11%) | 6 (15.79%) | 28 (37.84%) | ||
| 3D caps | |||||
| Absent | 18 (50%) | 34 (89.47%) | 52 (70.27%) | 0.0003 | Fisher’s Exact test |
| Present | 18 (50%) | 4 (10.53%) | 22 (29.73%) | ||
| Cellular swirls | |||||
| Absent | 17 (47.22%) | 38 (100%) | 55 (74.3%) | <0.0001 | Fisher’s Exact test |
| Present | 19 (52.78%) | 0 (0%) | 19 (25.6%) | ||
| Colloid | |||||
| Absent | 10 (27.78%) | 3 (7.89%) | 13 (17.57%) | 0.0002 | Fisher’s Exact test |
| Thick | 16 (44.44%) | 6 (15.79%) | 22 (29.73%) | ||
| Thick and thin | 0 (0%) | 4 (10.53%) | 4 (5.41%) | ||
| Thin | 10 (27.78%) | 25 (65.79%) | 35 (47.30%) | ||
| Giant cells | |||||
| Absent | 16 (44.44%) | 26 (68.42%) | 42 (56.76%) | 0.037 | Chi-square test, 4.33 |
| Present | 20 (55.56%) | 12 (31.58%) | 32 (43.24%) | ||
| Cyst macrophages | |||||
| Absent | 16 (44.44%) | 11 (28.95%) | 27 (36.49%) | 0.166 | Chi square test, 1.916 |
| Present | 20 (55.56%) | 27 (71.05%) | 47 (63.51%) | ||
| Nuclear grooves | |||||
| Many/frequent throughout the smear | 22 (61.11%) | 1 (2.63%) | 23 (31.08%) | <0.0001 | Chi-square test, 40.873 |
| Frequent in occasional groups of cells | 7 (19.44%) | 4 (10.53%) | 11 (14.86%) | ||
| Occasional throughout the smear | 5 (13.89%) | 7 (18.42%) | 12 (16.22%) | ||
| Absent | 2 (5.56%) | 26 (68.42%) | 28 (37.84%) | ||
| Nuclear grooves (present/absent) | |||||
| Absent | 2 (5.56%) | 26 (68.42%) | 28 (37.84%) | <0.0001 | Fisher’s Exact test |
| Present | 34 (94.44%) | 12 (31.58%) | 46 (62.16%) | ||
| Frequent Nuclear grooves (positive/negative) | |||||
| Negative | 14 (38.89%) | 37 (97.37%) | 51 (68.92%) | <0.0001 | Fisher’s Exact test |
| Positive | 22 (61.11%) | 1 (2.63%) | 23 (31.08%) | ||
| Intra-nuclear cytoplasmic inclusion | |||||
| Many/frequent throughout the smear | 11 (30.56%) | 0 (0%) | 11 (14.86%) | <0.0001 | Fisher’s Exact test |
| Frequent in occasional groups of cells | 8 (22.22%) | 0 (0%) | 8 (10.81%) | ||
| Occasional throughout the smear | 4 (11.11%) | 2 (5.26%) | 6 (8.10%) | ||
| Absent | 13 (36.11%) | 36 (94.73%) | 49 (63.51%) | ||
| Intra-nuclear cytoplasmic inclusion (present/absent) | |||||
| Absent | 13 (36.11%) | 36 (94.73%) | 49 (66.21%) | <0.0001 | Fisher’s Exact test |
| Present | 23 (63.89%) | 2 (5.26%) | 25 (33.78%) | ||
| Frequent Intra-nuclear cytoplasmic inclusion (positive/negative) | |||||
| Negative | 25 (69.44%) | 38 (100%) | 63 (85.14%) | 0.0001 | Fisher’s Exact test |
| Positive | 11 (30.56%) | 0 (0%) | 11 (14.86%) | ||
| Powdery chromatin | |||||
| Absent | 16 (44.44%) | 30 (78.95%) | 46 (62.16%) | 0.002 | Chi-square test, 9.357 |
| Present | 20 (55.56%) | 8 (21.05%) | 28 (37.84%) | ||
| Psammoma body | |||||
| Absent | 31 (86.11%) | 37 (97.37%) | 68 (91.89%) | 0.103 | Fisher’s Exact test |
| Present | 5 (13.89%) | 1 (2.63%) | 6 (8.11%) | ||
| Nuclear overlapping | |||||
| Absent | 10 (27.78%) | 18 (47.37%) | 28 (37.84%) | 0.082 | Chi-square test, 3.016 |
| Present | 26 (72.22%) | 20 (52.63%) | 46 (62.16%) | ||
| Cytoplasmic Vacuoles | |||||
| Absent | 26 (72.22%) | 35 (92.11%) | 61 (82.43%) | 0.033 | Fisher’s Exact test |
| Present | 10 (27.78%) | 3 (7.89%) | 13 (17.57%) | ||
| Squamous Metaplastic cells | |||||
| Absent | 18 (50%) | 31 (81.58%) | 49 (66.22%) | 0.004 | Chi-square test, 8.241 |
| Present | 18 (50%) | 7 (18.42%) | 25 (33.78%) | ||
| Nuclear atypia/enlargement | |||||
| Present | 25 (69.44%) | 8 (21.05%) | 27 (36.49%) | 0.020 | Chi-square test, 5.3667 |
| Absent | 11 (30.5.%) | 30 (31.58%) | 12 (16.22%) | ||
| Number of nuclei in giant cells | |||||
| Mean±SD | 10.25±15.14 | 3.32±5.28 | 6.69±11.67 | 0.039 | Mann-Whitney test; 510.5 |
| Median (IQR) | 4.5 (0-11.25) | 0 (0-7.25) | 0 (0-10) | ||
| Range | 0-55 | 0-20 | 0-55 |
Receiver operating characteristic curve with a combination of five cytological features to predict PTC
| PTC | Cytologic features |
|---|---|
| Area under the ROC curve (AUC) | 0.871 |
| Standard Error | 0.0398 |
| 95% Confidence interval | 0.773-0.938 |
|
| <0.0001 |
| Cut-off | >0 |
| Sensitivity (95% CI) | 83.33% (67.2%-93.6%) |
| Specificity (95% CI) | 78.95% (62.7%-90.4%) |
| PPV (95% CI) | 78.9% (62.7%-90.4%) |
| NPV (95% CI) | 83.3% (67.2%-93.6%) |
| Diagnostic accuracy | 81.08% |
Figure 2Receiver operating characteristic curve on combining five cytological features to predict PTC
Sensitivity, specificity, PPV, and NPV of cytological features to predict PTC
| PTC | Sensitivity (95% CI) | Specificity (95% CI) | AUC (95% CI) | PPV (95% CI) | NPV (95%CI) | Diagnostic accuracy |
|---|---|---|---|---|---|---|
| Papillae with cores | 61.11% (43.46%-76.86%) | 84.21% (68.75%-93.98%) | 0.73 (0.61-0.82) | 78.57% (59.05%-91.70%) | 69.57% (54.25%-82.26%) | 72.97% |
| Cellular swirls | 52.78% (35.49%-69.59%) | 100% (90.9%-100%) | 0.75 (0.64-0.84) | 100.00% (75.13%-100%) | 69.09% (56.45%-82.48%) | 77.02% |
| Nuclear grooves (positive/negative) | 61.11% (43.46%-76.86%) | 97.37% (86.19%-99.93%) | 0.79 (0.68-0.88) | 95.65% (78.05%-99.89%) | 72.55% (58.26%-84.11%) | 79.73% |
| Intra-nuclear cytoplasmic inclusion (positive/negative) | 30.56% (16.35%-48.11%) | 100.00% (90.75%-100.00%) | 0.65 (0.53-0.76) | 100.00% (71.51%-100.00%) | 60.32% (47.20%-72.43%) | 66.22% |
| Psammoma body | 13.89% (4.67%-29.50%) | 97.37% (86.19%-99.93%) | 0.56 (0.44-0.67) | 83.33% (35.88%-99.58%) | 54.41% (41.88%-66.55%) | 56.76% |
| Combined five Cytologic features | 83.33% (67.19%-93.63%) | 78.95% (62.68%-90.45%) | 0.81 (0.70-0.89) | 78.95% (62.68%-90.45%) | 83.33% (67.19%-93.63%) | 81.08% |
PPV: Positive predictive value; NPV: Negative predictive value CI: Confidence Interval
Figure 3Comparison of the number of nuclei in giant cells between groups 1 and 2 (nonparametric variable, Box whisker plot)
Clinical and histological details of PTC cases included in the study
| Characteristics | Frequency | Percentage |
|---|---|---|
| Type of surgery | ||
| HT | 8 | 22.22% |
| TT | 28 | 77.78% |
| Laterality | ||
| Bilateral | 9 | 25.00% |
| Isthmus | 2 | 5.56% |
| Left | 12 | 33.33% |
| Right | 11 | 30.56% |
| Right + Isthmus | 2 | 5.56% |
| Focality | ||
| Multifocal | 12 | 33.33% |
| Unifocal | 24 | 66.67% |
| LVI | ||
| Absent | 32 | 88.89% |
| Present | 4 | 11.11% |
| PNI | ||
| Absent | 35 | 97.22% |
| Present | 1 | 2.78% |
| Angioinvasion | ||
| Absent | 36 | 100.00% |
| T staging | ||
| T1a | 2 | 5.71% |
| T1b | 9 | 25.71% |
| T2 | 11 | 31.43% |
| T3a | 7 | 20.00% |
| T3b | 1 | 2.86% |
| T4a | 5 | 14.29% |
| N staging | ||
| 0 | 7 | 29.17% |
| 1 | 1 | 4.17% |
| 1a | 4 | 16.67% |
| 1b | 12 | 50.00% |
| M staging | ||
| 0 | 4 | 66.67% |
| 1 | 2 | 33.33% |
LVI: lymphovascular invasion; PNI: Perineural invasion; T: Tumor; N: Node; M: Metastasis
Figure 4Microphotograph showing intracytoplasmic inclusion (arrow) (May Grunwald Giemsa, ×400)
The Pentad of Cytological Features
| Papillae with cores |
| Cellular swirls |
| Nuclear grooves |
| Intra-nuclear cytoplasmic inclusion |
| Psammoma body |
Figure 5Microphotograph showing cellular swirls (arrow) (May Grunwald Giemsa, ×400)